Variant report
Variant | nsv613372 |
---|---|
Chromosome Location | chr9:10077180-10102903 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201272869 | chr9:10079003-10079004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530517244 | chr9:10079037-10079038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141699806 | chr9:10079074-10079075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183030132 | chr9:10079123-10079124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369975358 | chr9:10079134-10079135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566835744 | chr9:10079140-10079141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561016878 | chr9:10079164-10079165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529862865 | chr9:10079238-10079239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs60357083 | chr9:10079253-10079254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs117765480 | chr9:10079261-10079262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538593594 | chr9:10079262-10079263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187657709 | chr9:10079266-10079267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569189010 | chr9:10079323-10079324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150539707 | chr9:10079324-10079325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17618258 | chr9:10079326-10079327 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs537528669 | chr9:10079359-10079360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554785800 | chr9:10079361-10079362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192473499 | chr9:10079362-10079363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs718344 | chr9:10079379-10079380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62537262 | chr9:10079409-10079410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554362938 | chr9:10079437-10079438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577514117 | chr9:10079448-10079449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554745720 | chr9:10079456-10079457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546219739 | chr9:10079504-10079505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563181756 | chr9:10079506-10079507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185028237 | chr9:10079532-10079533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575160643 | chr9:10079535-10079536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187986823 | chr9:10079552-10079553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192197693 | chr9:10079563-10079564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139446585 | chr9:10079572-10079573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529693789 | chr9:10079592-10079593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546286015 | chr9:10079623-10079624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559955868 | chr9:10079705-10079706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532316341 | chr9:10079706-10079707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs149666725 | chr9:10079721-10079722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146270737 | chr9:10079815-10079816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531621975 | chr9:10079817-10079818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139462064 | chr9:10079835-10079836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568573282 | chr9:10079838-10079839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533774247 | chr9:10079839-10079840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10511532 | chr9:10079844-10079845 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs571090913 | chr9:10079856-10079857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540001488 | chr9:10079864-10079865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372380920 | chr9:10079866-10079867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556602389 | chr9:10079896-10079897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549537067 | chr9:10079897-10079898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576643040 | chr9:10079898-10079899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543866409 | chr9:10079902-10079903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10958877 | chr9:10079912-10079913 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs574084104 | chr9:10079928-10079929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10079000-10080400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr9:10079000-10080600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr9:10079000-10080600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr9:10079000-10080600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr9:10079200-10079800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr9:10079200-10080400 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr9:10079200-10080600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr9:10079200-10080600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:10079400-10079800 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr9:10079400-10080400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr9:10079400-10080400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr9:10079600-10080400 | Enhancers | Fetal Brain Female | brain |
13 | chr9:10080000-10080800 | Enhancers | Fetal Heart | heart |
14 | chr9:10085600-10085800 | ZNF genes & repeats | Aorta | Aorta |
15 | chr9:10085800-10096000 | Weak transcription | Aorta | Aorta |
16 | chr9:10096000-10096200 | Active TSS | Aorta | Aorta |